(Q53156044)
Statements
Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome. (English)
Pieter Sonneveld
Robert Z Orlowski
Tadeusz Robak
Joan Bladé
Jesús F San Miguel
Heather J Sutherland
Roman Hajek
Arnon Nagler
Andrew Spencer
Keith C Lantz
Sen H Zhuang
Jean-Luc Harousseau
DOXIL-MMY-3001 Study Investigators
1 February 2011
11
1
44-49